4//SEC Filing
Rosenblum Mark J 4
Accession 0001615219-24-000015
CIK 0001615219other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:37 PM ET
Size
5.5 KB
Accession
0001615219-24-000015
Insider Transaction Report
Form 4
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
- Award
Stock Option (right to buy)
2024-02-20+22,500→ 22,500 totalExercise: $0.57From: 2025-02-20Exp: 2034-02-19→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]25% of the options are vested on February 20, 2025, and 1/36 of the remaining options vest on each monthly anniversary thereafter for 36 months.
Documents
Issuer
Salarius Pharmaceuticals, Inc.
CIK 0001615219
Entity typeother
Related Parties
1- filerCIK 0001329154
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:37 PM ET
- Size
- 5.5 KB